Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Glaucoma Treatment Market

Glaucoma Treatment Market Share

Report ID: GMI5210
Published Date: Feb 2022
Report Format: PDF

Download Free Sample

Glaucoma Treatment Market Share

Some of the notable business players operating in the glaucoma treatment market include

Merck & Co., Inc.
Novartis AG
AERIE Pharmaceuticals, Inc.
Akorn operating company LLC
Cipla Inc
AbbVie
Bausch & Lomb Incorporated
Inotek Pharmaceuticals
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Santen Pharmaceutical Co., Ltd.

These industry players are implementing several growth strategies such as collaboration, partnership, acquisition & merger and product launch to gain competitive edge over others in glaucoma treatment industry.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for glaucoma treatment surpassed $5.5 billion in 2021 and is predicted to observe more than 3.2% CAGR during the forecast period of 2022-2028.

The open angle glaucoma disease accounted for over $4.5 billion in the global market in 2021 as there is a high incidence of this disease across the world and hypotensive drops are being extensively used to reduce the intraocular pressure caused by the ailment.

Prostaglandin analogs captured over 30% share of the overall industry in 2021 as the drugs can reduce the intraocular pressure and have several benefits, such as enhanced recovery rate in glaucoma treatment and high effectiveness of one dose.

North America glaucoma treatment market size is set to showcase 3.4% CAGR through 2028 due to the high occurrence of different forms of glaucoma and growing awareness of the importance of eye care among citizens.